The immune cell landscape of metastatic uveal melanoma correlates with overall survival

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-9966
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
The immune cell landscape of metastatic uveal melanoma correlates with overall survival ; volume:40 ; number:1 ; day:4 ; month:5 ; year:2021 ; pages:1-17 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (4.5.2021), 1-17, 12.2021

Creator
Tosi, Anna
Cappellesso, Rocco
Dei Tos, Angelo Paolo
Rossi, Valentina
Aliberti, Camillo
Pigozzo, Jacopo
Fabozzi, Alessio
Sbaraglia, Marta
Blandamura, Stella
Del Bianco, Paola
Chiarion-Sileni, Vanna
Rosato, Antonio
Contributor
SpringerLink (Online service)

DOI
10.1186/s13046-021-01947-1
URN
urn:nbn:de:101:1-2021090720543417714475
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tosi, Anna
  • Cappellesso, Rocco
  • Dei Tos, Angelo Paolo
  • Rossi, Valentina
  • Aliberti, Camillo
  • Pigozzo, Jacopo
  • Fabozzi, Alessio
  • Sbaraglia, Marta
  • Blandamura, Stella
  • Del Bianco, Paola
  • Chiarion-Sileni, Vanna
  • Rosato, Antonio
  • SpringerLink (Online service)

Other Objects (12)

Novel treatment paradigms for metastatic uveal melanoma

Novel treatment paradigms for metastatic uveal melanoma

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma

Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma

Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma

Verification of EZH2 as a druggable target in metastatic uveal melanoma

Verification of EZH2 as a druggable target in metastatic uveal melanoma

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events

Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives

Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Related objects